Clear cell papillary renal cell carcinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Apr 2024Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialRECRUITING
Aug 2023Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Oncorena AB — PHASE1, PHASE2

TrialRECRUITING
Jun 2022Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor, Inc. — PHASE1

TrialRECRUITING
Nov 2021CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

City of Hope Medical Center — PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Clear cell papillary renal cell carcinoma.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials
2Phase 1
2PHASE1, PHASE2
4Total recruiting
Search clinical trials for Clear cell papillary renal cell carcinoma

Recent News & Research

No recent news articles indexed yet for Clear cell papillary renal cell carcinoma.
Search PubMed for Clear cell papillary renal cell carcinoma

Browse all Clear cell papillary renal cell carcinoma news →

Specialist Network

Top 6 by expertise

View all Clear cell papillary renal cell carcinoma specialists →

Quick Actions